242 related articles for article (PubMed ID: 1463764)
1. Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1.
Zhou L; Leung BS
Biochim Biophys Acta; 1992 Dec; 1180(2):130-6. PubMed ID: 1463764
[TBL] [Abstract][Full Text] [Related]
2. Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells.
Humes HD; Beals TF; Cieslinski DA; Sanchez IO; Page TP
Lab Invest; 1991 Apr; 64(4):538-45. PubMed ID: 2016859
[TBL] [Abstract][Full Text] [Related]
3. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
4. Effects of sex steroids and growth factors on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells.
Ueda M; Fujii H; Yoshizawa K; Kumagai K; Ueki K; Terai Y; Yanagihara T; Ueki M
Jpn J Cancer Res; 1998 Dec; 89(12):1334-42. PubMed ID: 10081495
[TBL] [Abstract][Full Text] [Related]
5. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.
Mórocz IA; Schmitter D; Lauber B; Stahel RA
Br J Cancer; 1994 Nov; 70(5):850-6. PubMed ID: 7947089
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
7. [Growth regulation of human ovarian cancer cells by growth factors in vitro].
Chen X; Gao Y; Sun Y
Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):740-3. PubMed ID: 9387517
[TBL] [Abstract][Full Text] [Related]
8. Effect of TGF-beta 1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture.
Ilio KY; Sensibar JA; Lee C
J Androl; 1995; 16(6):482-90. PubMed ID: 8867596
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors.
Jozan S; Guerrin M; Mazars P; Dutaur M; Monsarrat B; Cheutin F; Bugat R; Martel P; Valette A
Int J Cancer; 1992 Nov; 52(5):766-70. PubMed ID: 1330935
[TBL] [Abstract][Full Text] [Related]
11. Effects of transforming growth factor alpha and beta on rabbit gastric epithelial cell proliferation: a preliminary report.
Nakajima N; Kuwayama H
J Clin Gastroenterol; 1993; 17 Suppl 1():S121-4. PubMed ID: 8283006
[TBL] [Abstract][Full Text] [Related]
12. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells.
Carruba G; Leake RE; Rinaldi F; Chalmers D; Comito L; Sorci C; Pavone-Macaluso M; Castagnetta LA
Steroids; 1994 Jul; 59(7):412-20. PubMed ID: 7974525
[TBL] [Abstract][Full Text] [Related]
13. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Simpson BJ; Bartlett JM; Macleod KG; Rabiasz G; Miller EP; Rae AL; Gordge P; Leake RE; Miller WR; Smyth J; Langdon SP
Br J Cancer; 1999 Mar; 79(7-8):1098-103. PubMed ID: 10098742
[TBL] [Abstract][Full Text] [Related]
15. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
Moriai T; Kobrin MS; Hope C; Speck L; Korc M
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
[TBL] [Abstract][Full Text] [Related]
16. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
[TBL] [Abstract][Full Text] [Related]
17. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody.
Karnes WE; Walsh JH; Wu SV; Kim RS; Martin MG; Wong HC; Mendelsohn J; Park JG; Cuttitta F
Gastroenterology; 1992 Feb; 102(2):474-85. PubMed ID: 1732118
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro.
Hölting T; Siperstein AE; Clark OH; Duh QY
Eur J Endocrinol; 1995 Feb; 132(2):229-35. PubMed ID: 7858744
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
Stromberg K; Collins TJ; Gordon AW; Jackson CL; Johnson GR
Cancer Res; 1992 Jan; 52(2):341-7. PubMed ID: 1309440
[TBL] [Abstract][Full Text] [Related]
20. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
